Resultados da busca - Michel Tulliez

  • Mostrando 1 - 8 resultados de 8
Refinar Resultados
  1. 1
    Role of Hemophagocytic Histiocytosis in the Etiology of Thrombocytopenia in Patients with Sepsis Syndrome or Septic Shock

    Role of Hemophagocytic Histiocytosis in the Etiology of Thrombocytopenia in Patients with Sepsis Syndrome or Septic Shock por François Stéphan, Brigitte Thiolière, E Verdy, Michel Tulliez

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas.

    Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. por Lucile Miquerol, Soledad López, Nathalie Cartier, Michel Tulliez, Michel Raymondjean, A Kahn

    Publicado em 1994
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors

    Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors por Fawzia Louache, A Henri, Ali Bettaı̈eb, Éric Oksenhendler, G Raguin, Michel Tulliez, William Vainchenker

    Publicado em 1992
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Etiology of portal vein thrombosis in adults

    Etiology of portal vein thrombosis in adults por Dominique Valla, Nicole Casadevall, Marie‐Geneviève Huisse, Michel Tulliez, Jean‐Didier Grangé, O. Müller, T. Binda, Bruno Varet, B Rueff, J P Benhamou

    Publicado em 1988
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

    Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation por Franck E. Nicolini, Sandrine Hayette, Sélim Corm, Emmanuel Bachy, Dominique Bories, Michel Tulliez, François Guilhot, Laurence Legros, Frédéric Maloisel, Jean‐Jacques Kiladjian, François‐Xavier Mahon, Quoc‐Hung Le, Mauricette Michallet, Catherine Roche‐Lestienne, Claude Preudhomme

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

    Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study por Delphine Réa, Franck E. Nicolini, Michel Tulliez, François Guilhot, Joëlle Guilhot, Agnès Guerci‐Bresler, Martine Gardembas, Valérie Coiteux, Gaëlle Guillerm, Laurence Legros, Gabriel Étienne, Jean‐Michel Pignon, Bruno Villemagne, Martine Escoffre‐Barbe, Jean‐Christophe Ianotto, Aude Charbonnier, Hyacinthe Johnson‐Ansah, Marie‐Pierre Noël, Philippe Rousselot, François‐Xavier Mahon

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

    Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib... por Philippe Rousselot, Aude Charbonnier, Pascale Cony‐Makhoul, Philippe Agapé, Franck E. Nicolini, Bruno Varet, Martine Gardembas, Gabriel Étienne, Delphine Réa, Lydia Roy, Martine Escoffre‐Barbe, Agnès Guerci‐Bresler, Michel Tulliez, Stéphane Prost, Marc Spentchian, Jean Michel Cayuela, Josy Reiffers, Jean‐Claude Chomel, Ali G. Turhan, Joëlle Guilhot, François Guilhot, François‐Xavier Mahon

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Congenital Dyserythropoietic Anemia Type I Is Caused by Mutations in Codanin-1

    Congenital Dyserythropoietic Anemia Type I Is Caused by Mutations in Codanin-1 por Orly Dgany, Nili Avidan, J. Delaunay, Tatyana Krasnov, Lea Shalmon, Hanna Shalev, Tal Eidelitz‐Markus, Joseph Kapelushnik, D Cattan, Alexandre Pariente, Michel Tulliez, Aurore Crétien, Pierre–Olivier Schischmanoff, Achille Iolascon, Eithan Fibach, Ariel Koren, Jochen Rößler, Martine Le Merrer, Isaac Yaniv, Rina Zaizov, Edna Ben‐Asher, Tsvyia Olender, Doron Lancet, J. Beckmann, Hannah Tamary

    Publicado em 2002
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: